Dernière minute
ITRider di Glovo e Deliveroo in sciopero a Firenze il 15 luglioTRAdalet Bakanı'nın Eşine Yönelik Eylem Hazırlığı Yapan 2 Şüpheli TutuklandıITPeppino di Capri, l'ultimo addio sull'isola che lo ha reso celebreITWimbledon: Sinner sfida Zverev nella finale maschileTRKumar Borcu İçin Sahte Evlilikler Yapan Kadın TutuklandıBRAdvogado é encontrado morto em rio durante pescariaTRPamukkale'de Orman Yangını: Atlı Jandarmalar Hortum Taşıyarak Destek VerdiVNMessi háo hức chạm trán Anh lần đầu tiên tại bán kết World CupBRHomem é encontrado dentro de geladeira após invadir casa em São José do Rio Preto (SP)ARاجتماع هام في سرت يعزز جهود توحيد المؤسسة العسكرية الليبيةITRider di Glovo e Deliveroo in sciopero a Firenze il 15 luglioTRAdalet Bakanı'nın Eşine Yönelik Eylem Hazırlığı Yapan 2 Şüpheli TutuklandıITPeppino di Capri, l'ultimo addio sull'isola che lo ha reso celebreITWimbledon: Sinner sfida Zverev nella finale maschileTRKumar Borcu İçin Sahte Evlilikler Yapan Kadın TutuklandıBRAdvogado é encontrado morto em rio durante pescariaTRPamukkale'de Orman Yangını: Atlı Jandarmalar Hortum Taşıyarak Destek VerdiVNMessi háo hức chạm trán Anh lần đầu tiên tại bán kết World CupBRHomem é encontrado dentro de geladeira após invadir casa em São José do Rio Preto (SP)ARاجتماع هام في سرت يعزز جهود توحيد المؤسسة العسكرية الليبية
Newsgather
BackKerala HC Case on Breast Cancer Drug Access Listed 57 Times Without Hearing
Kerala HC Case on Breast Cancer Drug Access Listed 57 Times Without Hearing
Urgent
Times of India1 g önceLawIndia

Kerala HC Case on Breast Cancer Drug Access Listed 57 Times Without Hearing

L'essentiel

  • A Kerala High Court case seeking access to life-saving breast cancer drug Ribociclib, filed in 2022, has been listed 57 times without a hearing.
  • The petitioner died during the case, which the court continued suo motu due to public interest.
  • A working group has urged the Chief Justice of India to expedite the hearing.

Résumé généré par IA

Taille de police

A Kerala High Court case seeking access to life-saving breast cancer drug Ribociclib, filed in 2022, has been listed 57 times without a hearing. The petitioner died during the case, which the court continued suo motu due to public interest. A working group has urged the Chief Justice of India to expedite the hearing.

Read the full article on Times of India

Sujets liés

This article was originally published by Times of India.

Articles liés

Plus sur ce sujetbreast cancer